IZZI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 9.857
AS - Asia 1.326
EU - Europa 1.109
SA - Sud America 283
AF - Africa 39
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.625
Nazione #
US - Stati Uniti d'America 9.802
SG - Singapore 638
CN - Cina 255
IT - Italia 240
BR - Brasile 238
IE - Irlanda 191
DE - Germania 153
HK - Hong Kong 142
RU - Federazione Russa 115
KR - Corea 108
GB - Regno Unito 96
UA - Ucraina 81
VN - Vietnam 63
FI - Finlandia 46
NL - Olanda 40
CA - Canada 35
FR - Francia 28
JP - Giappone 27
SE - Svezia 26
AT - Austria 21
AR - Argentina 20
ID - Indonesia 17
CZ - Repubblica Ceca 16
EG - Egitto 16
MX - Messico 16
IN - India 15
PL - Polonia 13
TR - Turchia 12
ZA - Sudafrica 10
ES - Italia 9
BE - Belgio 7
BD - Bangladesh 6
CH - Svizzera 6
CL - Cile 6
EC - Ecuador 5
GR - Grecia 5
KE - Kenya 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
NP - Nepal 4
VE - Venezuela 4
CO - Colombia 3
EU - Europa 3
HU - Ungheria 3
IQ - Iraq 3
LT - Lituania 3
PH - Filippine 3
SA - Arabia Saudita 3
TW - Taiwan 3
AZ - Azerbaigian 2
DK - Danimarca 2
DZ - Algeria 2
IL - Israele 2
IR - Iran 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PY - Paraguay 2
RO - Romania 2
TH - Thailandia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
CR - Costa Rica 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
MU - Mauritius 1
NG - Nigeria 1
NR - Nauru 1
PK - Pakistan 1
PT - Portogallo 1
SI - Slovenia 1
SV - El Salvador 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.625
Città #
Wilmington 2.560
Houston 2.459
Woodbridge 1.581
Fairfield 407
Singapore 338
Ashburn 332
Chandler 325
Seattle 195
Dublin 163
Beijing 159
Cambridge 159
Ann Arbor 149
Hong Kong 140
New York 117
Medford 115
Rome 97
Santa Clara 83
Dearborn 72
Los Angeles 65
Lawrence 54
The Dalles 54
Menlo Park 40
Munich 39
Buffalo 35
Council Bluffs 35
San Diego 34
Boardman 32
Jacksonville 32
Dallas 26
São Paulo 26
Moscow 24
Ho Chi Minh City 23
Milan 23
Helsinki 21
London 20
Tokyo 17
Brno 16
Chicago 16
Columbus 16
Seoul 16
Toronto 16
Hanoi 15
Amsterdam 14
Brooklyn 13
Redwood City 13
Jakarta 12
Norwalk 12
Stockholm 12
Atlanta 11
Salt Lake City 10
Vienna 10
Belo Horizonte 9
Cairo 9
Denver 9
Istanbul 9
Kilburn 9
Warsaw 9
Zhengzhou 9
Boston 8
Lappeenranta 8
Mexico City 8
Montreal 8
Nuremberg 8
San Francisco 8
Brussels 7
Guangzhou 7
Manchester 7
Nanjing 7
Palo Alto 7
Tsu 7
Bologna 6
Chennai 6
Johannesburg 6
Orem 6
Philadelphia 6
Phoenix 6
Porto Alegre 6
Redondo Beach 6
Santiago 6
Athens 5
Kunming 5
Nairobi 5
Poplar 5
Washington 5
Elk Grove Village 4
Engelhard 4
Hounslow 4
Kathmandu 4
Lucca 4
Redmond 4
Rio de Janeiro 4
Roebling 4
Tampa 4
Verona 4
Alexandria 3
Almirante Tamandaré 3
Biên Hòa 3
Brasília 3
Budapest 3
Caxias do Sul 3
Totale 10.543
Nome #
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 479
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population: further data and comments 465
Predicting seizures in untreated temporal lobe epilepsy using point-process nonlinear models of heartbeat dynamics 464
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 435
Optic Nerve dysfunction in obstructive sleep apnea: An electrophysiological study 429
Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases 419
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages 414
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population 406
Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time 403
Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? 364
Folic acid supplements during pregnancy in specific clinical settings: What dowe know about epilepsy? 361
MicroRNA expression is dysregulated in narcolepsy: A new evidence? 355
Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: Further data 353
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 353
Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study 348
Obstructive sleep apnoea and bone health 342
Continuous positive airway pressure treatment may improve optic nerve function in obstructive sleep apnea: An electrophysiological study 297
Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology 282
Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study 252
Postural and vestibular changes related to CPAP treatment in moderate-to-severe OSA patients: a 12-month longitudinal study 240
Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk? 232
Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms 227
Feasibility of automated detection of sleep apnea using implantable pacemakers and defibrillators: a comparison with simultaneous polysomnography recording 224
Heart rate variability in untreated newly diagnosed temporal lobe epilepsy: Evidence for ictal sympathetic dysregulation 223
CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study 220
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 218
Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine 218
Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course 217
Lower instantaneous entropy of heartbeat dynamics during seizures in untreated temporal lobe epilepsy 213
Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies 180
Seasonality of restless legs syndrome: symptom variability in winter and summer times 179
Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid 176
Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer’s disease 170
Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation 165
Pitolisant for treating narcolepsy comorbid with Parkinson's disease 153
Obstructive sleep apnea is associated with early but possibly modifiable Alzheimer's disease biomarkers changes 151
Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis 146
18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment 129
New revolution in the assessment of cerebrospinal fluid orexin-A: Enzyme-linked immunosorbent assay! 123
The actigraphic documentation of circadian sleep-wake rhythm dysregulation in myotonic dystrophy type 1 119
Heart rate variability parameters during psychogenic non-epileptic seizures: comparison between patients with pure PNES and comorbid epilepsy 116
Assessment of self-reported and objective daytime sleepiness in adult-onset myotonic dystrophy type 1 115
Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy? 91
Autonomic symptoms, cardiovascular and sudomotor evaluation in de novo type 1 narcolepsy 91
Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy 89
Correction to: Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course 76
Neuroimaging findings in leukoencephalopathy with calcifications and cysts: case report and review of the literature 72
Cognitive and Neuropsychiatric Profiles in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease. 72
Obstructive sleep apnea syndrome and Alzheimer's disease pathology: may continuous positive airway pressure treatment delay cognitive deterioration? 70
Brivaracetam as early add-on treatment in patients with focal seizures: a retrospective, multicenter, real-world study 68
Sleep-wake cycle dysregulation in idiopathic REM sleep behaviour disorder 67
Nocturnal hypoxia and sleep fragmentation may drive neurodegenerative processes: the compared effects of obstructive sleep apnea syndrome and periodic limb movement disorder on Alzheimer's disease biomarkers 67
Clinical characteristics of a large cohort of patients with narcolepsy candidate for pitolisant: a cross-sectional study from the Italian PASS Wakix® Cohort 64
Periodic sharp wave complexes identify a distinctive phenotype in Creutzfeldt-Jacob disease. 62
Derivation and Validation of a Phenoconversion-Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder 59
Cerebrospinal-fluid biomarkers for predicting phenoconversion in patients with isolated rapid-eye movement sleep behavior disorder 58
Perampanel may represent an effective treatment for the prevention of migraine comorbid with epilepsy 57
Depressive symptoms in patients with epilepsy and clinically associated features in a single tertiary center 55
Insular monoaminergic deficits in prodromal α-synucleinopathies 49
Brainstem impairment in obstructive sleep apnoea and the effect of CPAP treatment: an electrophysiological blink reflex study 49
Neuropsychiatric, neuropsychological, and neuroimaging features in isolated REM sleep behavior disorder: The importance of MCI 47
Sleep Dysregulation Is Associated with 18F-FDG PET and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease 42
A preliminary study investigating the clinical potential of measuring cerebrospinal-fluid lactate levels in patients with narcolepsy type 1 and 2 40
Continuous positive airway pressure treatment improves bone mineral density in men affected by severe obstructive sleep apnea syndrome 38
More than sleep and wake disturbances: An actigraphic study showing the sleep-wake pattern dysregulation in epilepsy 38
Generalized Fast Discharges Along the Genetic Generalized Epilepsy Spectrum: Clinical and Prognostic Significance 35
OBSTRUCTIVE SLEEP APNEA AS A RISK FACTOR FOR OSTEOPENIA AND OSTEOPOROSIS IN THE MALE POPULATION 28
Effectiveness of Highly Purified Cannabidiol in Refractory and Super-Refractory Status Epilepticus: A Case Series 27
null 7
Totale 12.893
Categoria #
all - tutte 41.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.484


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.059 0 0 0 0 0 300 295 224 43 106 68 23
2021/2022661 27 46 26 11 16 18 65 15 33 53 40 311
2022/2023846 103 77 39 104 69 174 65 53 84 16 37 25
2023/2024443 43 10 24 23 36 146 21 37 8 27 6 62
2024/20251.391 62 286 148 97 36 121 67 67 142 122 140 103
2025/20261.296 251 80 332 301 243 89 0 0 0 0 0 0
Totale 12.893